Log in to save to my catalogue

Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazod...

Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazod...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_96bbde8a6da74501ad7b64be14c4c66f

Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone-risperidone combination: a case report

About this item

Full title

Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone-risperidone combination: a case report

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Neuropsychiatric disease and treatment, 2017-01, Vol.13, p.775-777

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

Neuromyelitis optica (NMO) is a relapsing disease that typically affects the spinal cord and optic nerves. So far, a few studies have reported pharmacologic treatment for psychiatric symptoms in patients with NMO spectrum disorder (NMOSD). However, no literature has described psychomotor agitation associated with the disease and its treatment. We r...

Alternative Titles

Full title

Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone-risperidone combination: a case report

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_96bbde8a6da74501ad7b64be14c4c66f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_96bbde8a6da74501ad7b64be14c4c66f

Other Identifiers

ISSN

1176-6328,1178-2021

E-ISSN

1178-2021

DOI

10.2147/NDT.S132516

How to access this item